Xianzhe D. Dong
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Generic vs. brand-name pramipexole: effectiveness, safety, and cost comparison in a multicenter retrospective cohort study.
Journal: Frontiers in aging neuroscience
Published: May 06, 2026
Post-marketing safety of lecanemab: a real-world study based on FAERS database, multicenter cohort and network pharmacology.
Journal: Frontiers in psychiatry
Published: March 04, 2026
Association of blood-activating commercial Chinese polyherbal preparation with clinical outcomes in older patients with ischemic cardiovascular or cerebrovascular diseases: a real-world cohort study.
Journal: Frontiers in pharmacology
Published: February 27, 2026
Correction: Comparison of treatment patterns, efficacy and safety between generic and branded Atorvastatin users in China: a multicenter, retrospective propensity score‑matched cohort study.
Journal: Lipids in health and disease
Published: October 24, 2025
Network Pharmacology Analysis and Animal Experiment Validation of Penthorum chinense Pursh in Treating Cholestatic Liver Disease.
Journal: Current pharmaceutical design
Published: October 09, 2025
CXCL12 upregulates PD-L1 expression and promotes M2 polarisation of tumour-associated macrophages to confer anti-PD-1 resistance in gastric cancer.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: September 15, 2025
Therapeutic equivalence and switching between biosimilar and reference insulins: A systematic review and meta-analysis of randomised controlled trials.
Journal: Diabetes, obesity & metabolism
Published: August 17, 2025
Research progress in the construction and application of immunotherapy resistance models.
Journal: Cancer immunology, immunotherapy : CII
Published: August 06, 2025
Single-cell RNA sequencing reveals the ameliorative effects of Kai-Xin-San on depression via regulating neuroplasticity and inflammation in the hypothalamus of rats.
Journal: Neuroscience
Published: May 09, 2025
Updating the potentially inappropriate medication (PIM)-China criteria for 2024: a Delphi consensus study for improved medication safety in older adults.
Journal: International journal of clinical pharmacy
Published: February 23, 2025
Reply: [Post-marketing safety concerns with Lecanemab: a disproportionality analysis using the FDA adverse event reporting system].
Journal: Alzheimer's research & therapy
Published: February 21, 2025
Comparison of treatment patterns, efficacy and safety between generic and branded atorvastatin users in China: a multicenter, retrospective propensity score-matched cohort study.
Journal: Lipids in health and disease
Published: January 10, 2025
Last Updated: 09/26/2026